AI assistant
SKIN ELEMENTS LIMITED — Capital/Financing Update 2021
Oct 4, 2021
65803_rns_2021-10-04_ab77a294-1261-42be-afff-6509fc532c32.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
5 October 2021
Placement finalised raising $2.1 million
Australian natural skin care company Skin Elements Limited (ASX: SKN) (the ‘ Company ’) is pleased to advise that it has finalised the placement announced on 31 August 2021 raising additional funds to a total of $2.1 million in cash to fund its stated business plans including the launch of is new TGA registered SuprCuvr hospital grade disinfectant.
The Company has issued 26,250,000 ordinary fully paid shares for $2,100,000 in cash (before costs) in a private placement to sophisticated investors under the Company’s ASX Listing Rule 7.1 and 7.1A placement capacity.
An updated Appendix 3B, an Appendix 2A application and Cleansing Prospectus will be lodged in relation to this placement.
This announcement is approved by the Board of directors of Skin Elements Limited.
END
About Skin Elements
Skin Elements is an award winning Australian owned and operated ASX listed health and wellness company focused on the development of scientifically proven formulations using natural and organic ingredients. Skin Elements’ innovative approach to chemical free therapeutics has enabled the creation of a portfolio of products that have been sold and distributed across the world. Its flagship products include the plant based SuprCuvr Hospital Grade disinfectant and Invisi Shield sanitiser, Soléo Organics natural and organic sunscreen range, PapayActivs therapeutic pawpaw skincare range and Elizabeth Jane Natural Cosmetics brand.
Further information is available via the Company website: http://skinelementslimited.com
==> picture [587 x 65] intentionally omitted <==
==> picture [587 x 66] intentionally omitted <==
For further information, please contact: Peter Malone Media and Investor Inquiries Executive Chairman James Moses Skin Elements Limited Mandate Corporate T: +61 439 430 770 T: +61 420 991 574 E: [email protected] E: [email protected]
==> picture [398 x 107] intentionally omitted <==
==> picture [521 x 67] intentionally omitted <==